| Article 89 Published on December 1, 2016 |
Risks To Cognitive Decline In Patients With Diabetes
A study by researchers shows patients with type 2 diabetes (T2D) are at risk of cognitive decline and diabetes treatment may decrease cognitive decline in older patients. 7,740 individuals from Chicago Health and Aging Project aged 65 years were tracked by researchers and found that Black and European groups with type ii diabetes (T2D) have faster rates of cognitive decline compared with individuals without diabetes. Researchers investigated the nature of cognitive decline during the early stage of the disease. They found small cognitive decrease already present during early stages of type 2 diabetes (T2D) and during prediabetes stage in patients. As diabetic individual ages, there will be an increase in cognitive decline and risk of dementia. Risk factors for the early cognitive decline for patients with type 2 diabetes (T2D) are
Cognitive decline in an individual results in
- A decrease in memory function
- The decrease in information processing speed
- A decrease in the function execution
Researchers unable to find out how cognitive decrements progress over time. Researchers say treating type 2 diabetes (T2D) during early stages can delay development of cognitive decline. The study findings were published in Diabetes Care.
Macrovascular disease : A disease to large blood vessels such as coronary arteries, arteries in the brain, arteries in the limbs and the aorta of the body. This may happen for a long time diabetic individual. Risk factors for macrovascular disease are
- High blood pressure (BP)
- High levels of blood sugar
- Development of insulin resistance
- High cholesterol levels in the body
- Smoking habit
Complications with the macrovascular disease are
Wearable Belt Type Medical Device To Treat Diabetes In Obese Individuals
Researchers from Kumamoto University, Japan have developed a wearable device to treat patients with type 2 diabetes (T2D) even if an individual is obese. The device can decrease blood sugar levels, improve insulin sensitivity and decrease visceral fat. Researchers found improvements in fatty liver markers, chronic inflammation, renal function and lipid profile. Human body activates heat shock response (HSR) in response to stress levels. But HSR functionality was reduced in patients with type 2 diabetes (T2D). HSP72 is a main protein of HSR. Researchers found that by restoring HSP72 functionality, abnormalities related to high sugar levels can be normalized. Researchers restored HSP72 functionality by mild electrical stimulation (MES) with heat shock (HS). Researchers developed a belt-type medical device, simple to use and can be attached to the abdomen with the new technology. The benefits are similar to physical exercise and it is very useful to overweight, disable or elderly individuals. Lead researcher of the team is Tatsuya Kondo and the study findings were published in the journal Scientific Reports.
About Acanthosis Nigricans
Acanthosis nigricans is a skin disorder or disease that makes skin thick and velvety. Skin changes to brown to black color patches or markings in the areas such as the back of the neck, body folds, forehead, navel, creases, groin, armpits and under the breasts. This is not a harmful disease and effects people with conditions such as
- Having insulin levels higher compared with individuals of the same weight
- Obese individuals
- People with pre-diabetes and diabetes
- Family medical history
- Common in native Americans
Doctors can diagnose the disease through physical examination and patient family medical history. Treatment options include
- Reducing insulin levels by taking the special diet. Insulin levels rise if an individual eats wrong foods
- Avoiding some medications causing this disease
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.